Independent pharmacists from Louisiana and Massachusetts and the New Jersey and North Carolina Associations of Pharmacists have joined the Pharmacists for the Protection of Patient Care (P3C) coalition of pharmacists. The nonprofit organization's goal is to educate federal lawmakers and the public about the cost-critical health implications of not taking medication as directed.
The growing effort emphasizes the heightened sense of urgency felt by the nation's pharmacists to raise awareness of medication misuse, its impact on patients nationwide, and the solutions pharmacists can apply to stop patients from misusing medications.
The coalition supports widespread implementation of Medication Therapy Management Programs (MTMPs) in pharmacies across the United States. MTMP allows pharmacists to help patients more effectively manage their multiple medications and ensure that seniors receive the full therapeutic outcomes of drugs.
"This swell of support demonstrates the pharmacy community's commitment to making medication misuse a top priority in the public and political sphere. It will increase our ability to effect change at the Federal level, helping prevent needless deaths caused by the avoidable problem of medication misuse," said Ian E. Salditch, chief lobbyist for P3C and chief executive officer of Medicine-On-Time.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs